Patient Preference in Blood Pressure Therapy

Arterial Hypertension Clinical Trial

Official title:

Patient Preference in Blood Pressure Therapy: Questioning of Patients With Hypertension

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03548623
• Other study ID #: CRC2017PPiB
• Status: Completed
• Start date: May 1, 2017
• Est. completion date: October 31, 2018

Study information

• Verified date: February 2020
• Source: University of Erlangen-Nürnberg Medical School
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Written surveys of patients with high blood pressure are designed to determine how they would likely decide if, in addition to taking medication, they had another option to treat their hypertension.

The alternative treatment option is renal sympathetic denervation using catheter ablation. This new treatment method is not yet used in the standard care. Currently, studies are being conducted in specific centers to demonstrate the efficacy of this treatment.

Questionnaires are used to determine the preference of patients for one or the other option of hypertension treatment. So far, there are no findings.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: October 31, 2018
• Est. primary completion date: April 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• untreated Hypertension

• treated Hypertension with one or more medications

Exclusion Criteria:

• illiteracy

Related Conditions & MeSH terms

• Arterial Hypertension
• Hypertension

Locations

Country	Name	City	State
Germany	Institute for Preventive Medicine	Nuremberg

Sponsors (2)

Lead Sponsor	Collaborator
Roland E. Schmieder	Institute for Preventive Medicine

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Preference of treatment	Questionnaires	3 months